🔎 Trials Near Me

Home › Meningioma › Massachusetts › Boston

Meningioma clinical trials in Boston, MA

6 studies for Meningioma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

RecruitingPhase 2
  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT02523014

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

RecruitingPhase 2
  • Dana-Farber/Harvard Cancer Center, Boston
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06955169

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

RecruitingPhase 2
  • Massachusetts General Hospital, Boston
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT07428616

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

RecruitingPhase 2
  • Massachusetts General Hospital, Boston
Ages 12 and older · All sexes · Updated Sep 2, 2026 · NCT04374305

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

RecruitingPhase 2
  • Mass General, Boston
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT07533942

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

RecruitingObservational study
  • Beth Israel Deaconess Medical Center, Boston
  • Beth Israel Deaconess Medical Center, Boston
All ages · All sexes · Updated Jul 22, 2026 · NCT04427384

Meningioma trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.